Placebo (QVA149)

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Chronic Obstructive Pulmonary Disease

Phase 3

Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.

CompletedNCT02487498

Novartis PharmaceuticalsChronic Obstructive Pulmonary Disease

Start: 2015-07-27End: 2016-09-06Updated: 2018-04-02

Efficacy and Safety Study of QVA149 in COPD Patients

CompletedNCT02487446

Novartis PharmaceuticalsChronic Obstructive Pulmonary Disease

Start: 2015-07-28End: 2016-09-12Updated: 2017-12-26

Related Papers

Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.

2017-10-0927 citations